138 related articles for article (PubMed ID: 14640963)
1. H2O2-induced platelet aggregation and increase in intracellular Ca2+ concentration are blocked by inhibitors of intracellular signaling.
Loiko EN; Samal AB; Shulyakovskaya SM
Biochemistry (Mosc); 2003 Nov; 68(11):1210-6. PubMed ID: 14640963
[TBL] [Abstract][Full Text] [Related]
2. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis.
Nakano Y; Oshima T; Matsuura H; Kajiyama G; Kambe M
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):961-7. PubMed ID: 9633938
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted effects of arachidonic acid and interaction with cyclic nucleotides in human platelets.
Rukoyatkina N; Shpakova V; Panteleev M; Kharazova A; Gambaryan S; Geiger J
Thromb Res; 2018 Nov; 171():22-30. PubMed ID: 30240944
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
Matsuoka I; Nakahata N; Nakanishi H
Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
Liao CH; Ko FN; Wu CL; Teng CM
J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
[TBL] [Abstract][Full Text] [Related]
6. p-Aminobenzoic acid and its metabolite p-acetamidobenzoic acid inhibit agonist-induced aggregation and arachidonic acid-induced [Ca2+]i transients in human platelets.
Barbieri B; Stain-Malmgren R; Papadogiannakis N
Thromb Res; 1999 Sep; 95(5):235-43. PubMed ID: 10515288
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effect of demethyldiisoeugenol.
Liao CH; Ko FN; Kuo YH; Teng CM
Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
9. [Drugs interfering with platelet function].
Marino A; De Natale G
Clin Ter; 1990 Feb; 132(3):193-9. PubMed ID: 2159394
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting platelet cyclic GMP levels during aggregation induced by collagen and by arachidonic acid.
Davies T; Davidson MM; McClenaghan MD; Say A; Haslam RJ
Thromb Res; 1976 Oct; 9(4):387-405. PubMed ID: 185743
[No Abstract] [Full Text] [Related]
11. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.
Anfossi G; Russo I; Massucco P; Mattiello L; Balbo A; Cavalot F; Trovati M
Thromb Res; 2001 May; 102(4):319-30. PubMed ID: 11369425
[TBL] [Abstract][Full Text] [Related]
12. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
13. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP.
Qi R; Ozaki Y; Satoh K; Yang LB; Asazuma N; Yatomi Y; Kume S
J Cardiovasc Pharmacol; 1996 Aug; 28(2):215-22. PubMed ID: 8856476
[TBL] [Abstract][Full Text] [Related]
14. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet mechanisms of TA-993 and its metabolite MB3 in ADP-induced platelet aggregation.
Katoh M; Karasawa T; Doi H; Odawara A; Takagi M; Ikeo T; Narita H
Eur J Pharmacol; 2000 Jul; 399(2-3):91-6. PubMed ID: 10884507
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
17. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
18. Adenosine diphosphate-induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t-PAPS): Role of P2Y
Leonardi GR; Lescano CH; Costa JL; Mazetto B; Orsi FA; Monica FZ
J Thromb Haemost; 2022 Jul; 20(7):1699-1711. PubMed ID: 35395698
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
Nagakura N; Saeki T; Harada K; Yoshitake S; Kobayashi S; Yamanaka T; Saito I
Biol Pharm Bull; 1996 Jun; 19(6):828-33. PubMed ID: 8799481
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
